Long-term Results of Ponatinib in CP-CML: 4-Year Minimum...

Clinical Lymphoma Myeloma and Leukemia 2015 / 09 Vol. 15

Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Follow-up of a Phase 1 Trial

Kantarjian, Hagop M., Talpaz, Moshe, Cortes, Jorge E., Shah, Neil P., Bixby, Dale L., Flinn, Ian W., O’Hare, Thomas J., Hu, Simin, Rivera, Victor M., Clackson, Tim, Conlan, Maureen G., Haluska, Frank
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.072
Date:
September, 2015
File:
PDF, 77 KB
english, 2015
Conversion to is in progress
Conversion to is failed